The GLP-1 medication wave is reshaping not just healthcare but the entire food and supplement supply chain — and a new entrant is positioning directly inside that gap. Lean On, co-founded by sisters Alesha and Natalie Peluso, has launched two nutritional supplement products — DeepSculpt and LiquidGold — engineered specifically for people undergoing rapid weight loss on GLP-1 medications such as semaglutide and tirzepatide.

For food and beverage operators, retailers, and brand buyers, the launch is a signal worth tracking: a new consumer segment defined by dramatically reduced caloric intake and elevated nutritional risk is generating its own product category in real time.

The Market Context

GLP-1 prescriptions have surged across the United States, with tens of millions of patients now managing appetite suppression that can reduce daily food consumption by 30% to 50%. That reduction creates measurable deficits in protein, micronutrients, and essential fatty acids — the precise gaps Lean On says its two SKUs address. DeepSculpt appears positioned around body-composition support, while LiquidGold targets nutrient density and recovery, though full formulation details were not disclosed at launch.

The supplement segment targeting GLP-1 users is attracting activity from established nutrition brands, direct-to-consumer startups, and increasingly, foodservice-adjacent operators looking to build functional menu or retail programs around this population. Grocery buyers and specialty wellness retailers are beginning to carve dedicated shelf space for this cohort, a development that mirrors how the sports-nutrition aisle matured in the early 2000s.

What This Signals for Operators

For hospitality and foodservice operators — particularly those running health-focused concepts, hotel wellness programs, or medically adjacent dining — the GLP-1 consumer represents a guest who is eating less but demanding far more nutritional precision. Menu engineering for this group is not about portion reduction alone; it requires protein density, micronutrient completeness, and digestive tolerability in every dish.

Brand launches like Lean On's also signal a procurement opportunity. Operators building private-label wellness lines, spa menus, or in-room nutrition programs should be evaluating the GLP-1 support category now, before it becomes a commoditized shelf staple. Supplier conversations about protein-forward bases, liquid nutrition formats, and micronutrient fortification are increasingly relevant to this channel. The Brand Launch Department lens here is clear: first-mover positioning in GLP-1-adjacent product programs carries outsized value while the category is still defining itself.

Distribution strategy will be the next variable to watch. Brands entering this space through direct-to-consumer channels often migrate toward specialty grocery, then pharmacy, then foodservice — a pattern visible across functional beverage and nutrition trends over the past decade. Operators with existing wellness retail or grab-and-go infrastructure are well-placed to evaluate early distribution partnerships before major brokers lock in exclusives.

Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.

Frequently Asked Questions

What's the actual market size for GLP-1 supplement products right now?

Tens of millions of semaglutide and tirzepatide patients are in active use across the US, with prescriptions accelerating monthly. The category itself is nascent—we're seeing early-stage entrants like Lean On alongside major nutrition brands quietly launching GLP-1-adjacent formulations, meaning shelf space and customer acquisition velocity will define winners in the next 12-18 months.

Should my hotel or restaurant foodservice program build around GLP-1 guests?

Yes, if you're operating premium hospitality or health-focused concepts. GLP-1 users need 30-50% fewer calories but 40% more protein density and micronutrient load—that's a specific menu engineering play. Forward operators are already designing small-format, high-protein plates and pairing in-house supplements; this positions you against commodity room service.

Are Lean On's DeepSculpt and LiquidGold the only options for my retail shelf?

No. Established players like Herbalife, USANA, and direct-to-consumer brands are actively formulating for this cohort, and more launches are coming in Q1 2025. Your strategy should be vetting formulation transparency, third-party testing, and whether the brand has clinical or practitioner backing—don't just chase the new shiny.

What nutritional gaps do GLP-1 users actually have?

Protein, B vitamins, iron, calcium, and essential fatty acids—the gaps mirror what bariatric surgery populations face, but faster and often without clinical supervision. That's why supplementation plays are legitimate, not hype; you're addressing real metabolic deficits that impact guest or customer retention and satisfaction.

How do I position this in grocery without looking opportunistic?

Frame it as clinical nutrition, not weight loss. Partner with registered dietitians, certify through NSF or USP, and place the SKU near functional foods and medical nutrition sections—not the diet aisle. Specialty wellness retailers are already doing this successfully; follow their merchandising playbook.